Ceribell CBLL
NASDAQ CBLL
$24.31 -0.58 (-2.33%)
As of: Aug 20, 2026 · 3:59 PM EDT

Ceribell (CBLL) Selling, General & Administrative (2023 - 2026)

Ceribell (CBLL) Selling, General & Administrative (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 4.03 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 2.23 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 3.06 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 1.80 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 561.20 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 358.70 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 1.12 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -179.00 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 369.70 Mn
10 Ceribell 923.42 Mn 794.16 Mn 25.94 Mn 14.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 14.76 Mn
Mar 31, 2026 15.32 Mn
Dec 31, 2025 12.12 Mn
Sep 30, 2025 11.04 Mn
Jun 30, 2025 11.36 Mn
Mar 31, 2025 9.94 Mn
Dec 31, 2024 9.97 Mn
Sep 30, 2024 9.03 Mn
Jun 30, 2024 7.61 Mn
Mar 31, 2024 7.24 Mn
Dec 31, 2023 5.99 Mn
Sep 30, 2023 4.99 Mn